How can we help you?
The latest from MDFA

Our latest edition of Vision Voice is here
Welcome to the latest edition of Vision Voice.

Our latest newsletter is out now
Read the Autumn 2025 edition of the Vision Voice newsletter.

Government defers MBS private health insurance reclassification
Statement from Dr Kathy Chapman, CEO, Macular Disease Foundation Australia

Opinion Editorial: Sight preservation should be a national priority
By The Hon. Jillian Skinner, AM, former NSW Minister for Health. This article was originally published by News Corp.

Living with macular disease consumes 12% of age pension payments
Macular Disease Foundation Australia calls on next Federal Government to bulk-bill sight-saving eye injections for pensioners.

Call to Federal Government to bulk bill eye injections for pensioners
We have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.

Macular Disease Foundation Australia welcomes new treatment for Geographic Atrophy
The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment pegcetacoplan (SYFOVRE®) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.

Read our latest newsletter today
Welcome to the latest edition of Vision Voice.

Our latest newsletter is out now
Read the Summer 2024 edition of the Vision Voice newsletter.